Skip to main content
. 2021 Mar 8;11:5433. doi: 10.1038/s41598-021-84782-w

Figure 2.

Figure 2

Binding of famotidine to PLpro and 3CLpro analyzed by SPR. Soluble biotinylated PLpro (a, b) and 3CLpro (c, d) were immobilized on a neutravidin-coated sensor chip and a range of compound concentrations were injected with solvent (DMSO) corrections. Both, (a) compound 6, the known PLpro inhibitor and (c) ML188, the 3CLpro inhibitor displayed dose-dependent binding to PLpro and 3CLpro, respectively. Whereas, (b, d) no binding of famotidine was detected to either protein. The dissociation constant (Kd) values for the control compounds are shown in Table S1 (Supplementry Information).